Effect of the CXCR2 antagonist danirixin on symptoms and health status in COPD

Aili L. Lazaar, Bruce E. Miller, Maggie Tabberer, John Yonchuk, Nancy Leidy, Claire Ambery, Jackie Bloomer, Henrik Watz, Ruth Tal-Singer

Source: Eur Respir J, 52 (4) 1801020; 10.1183/13993003.01020-2018
Journal Issue: October
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Aili L. Lazaar, Bruce E. Miller, Maggie Tabberer, John Yonchuk, Nancy Leidy, Claire Ambery, Jackie Bloomer, Henrik Watz, Ruth Tal-Singer. Effect of the CXCR2 antagonist danirixin on symptoms and health status in COPD. Eur Respir J, 52 (4) 1801020; 10.1183/13993003.01020-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: